Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HIV-1 in Appropriate Patients
.
Show all posts
Showing posts with label
HIV-1 in Appropriate Patients
.
Show all posts
Friday, November 16, 2018
FDA Approves Merck’s Pifeltro (doravirine) for the Treatment of HIV-1 in Appropriate Patients
›
Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved Pife...
Wednesday, November 14, 2018
FDA Approves Merck’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients
›
In continuation of my update on Imbruvica ( ibrutinib ) The Janssen Pharmaceutical Companies of Johnson & Johnson today announ...
›
Home
View web version
